National Institute on Aging seed funding enables Alzheimer's disease startups to reach key value inflection points
| Autor: | Samir Sauma, Armineh L Ghazarian, Pragati Katiyar, Todd Haim |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Epidemiology
business.industry Health Policy Psychological intervention Small business Commercialization Research Personnel United States Fiscal year Psychiatry and Mental health Cellular and Molecular Neuroscience Seed money Developmental Neuroscience National Institutes of Health (U.S.) Alzheimer Disease Value (economics) National Institute on Aging (U.S.) Portfolio Humans Neurology (clinical) Business Small Business Geriatrics and Gerontology Marketing Small Business Innovation Research |
| Zdroj: | Alzheimer'sdementia : the journal of the Alzheimer's Association. 18(2) |
| ISSN: | 1552-5279 |
| Popis: | Introduction The National Institute on Aging (NIA) provides funding to academic researchers and small businesses working in the Alzheimer's Disease (AD) and AD-related dementia (ADRD) fields to help commercialize their products. The NIA uses Small Business Innovation Research (SBIR) awards to bridge the funding gap in the diagnostic, therapeutic, and care interventions areas, enabling startups to reach key value inflection points to achieve scientific milestones. Methods Only publicly available information is reported. The National Institutes of Health Report Portfolio Online Reporting Tool database and the commercial database Global Data, were used to track the progress of companies that received SBIR or Small Business Technology Transfer (STTR) funding from the NIA. Results Since 2008, the NIA has awarded $280 million-including $207 million from fiscal year (FY) 2015 to FY 2019-in new small business program awards for AD/ADRD research. Discussion NIA seed capital and mentoring programs are critical resources to help small businesses reach key value inflection points and advance their research from concept to commercialization. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|